Landmark analysis for predictive value of MRD for PFS by N-PCR and RQ-PCR
Time . | Median follow-up (mo) . | Patients assessed (positive/negative) . | PFS at median follow up . | |||||
---|---|---|---|---|---|---|---|---|
N-PCR . | RQ-PCR . | |||||||
Positive (%) . | Negative (%) . | P value . | Positive (%) . | Negative (%) . | P value . | |||
M5 | 38 | 29/71 | 62 | 69 | .34 | 54 | 72 | .11 |
M8 | 34 | 15/84 | 39 | 72 | .007 | 0 | 74 | <.001 |
M12 | 30 | 11/65 | 54 | 78 | .042 | 0 | 78 | <.001 |
M18 | 24 | 5/72 | 40 | 81 | .013 | 34 | 78 | .079 |
M24 | 19 | 9/60 | 44 | 90 | <.001 | 20 | 88 | <.001 |
Time . | Median follow-up (mo) . | Patients assessed (positive/negative) . | PFS at median follow up . | |||||
---|---|---|---|---|---|---|---|---|
N-PCR . | RQ-PCR . | |||||||
Positive (%) . | Negative (%) . | P value . | Positive (%) . | Negative (%) . | P value . | |||
M5 | 38 | 29/71 | 62 | 69 | .34 | 54 | 72 | .11 |
M8 | 34 | 15/84 | 39 | 72 | .007 | 0 | 74 | <.001 |
M12 | 30 | 11/65 | 54 | 78 | .042 | 0 | 78 | <.001 |
M18 | 24 | 5/72 | 40 | 81 | .013 | 34 | 78 | .079 |
M24 | 19 | 9/60 | 44 | 90 | <.001 | 20 | 88 | <.001 |